IRIS
CASSANO, TOMMASO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.849
NA - Nord America 2.806
AS - Asia 1.327
SA - Sud America 11
Continente sconosciuto - Info sul continente non disponibili 8
AF - Africa 2
Totale 7.003
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.789
IE - Irlanda 932
CN - Cina 835
UA - Ucraina 628
SE - Svezia 432
IT - Italia 302
DE - Germania 162
FR - Francia 153
SG - Singapore 145
IN - India 141
FI - Finlandia 110
TR - Turchia 100
KR - Corea 77
GB - Regno Unito 54
AT - Austria 26
BE - Belgio 13
CA - Canada 13
VN - Vietnam 13
CZ - Repubblica Ceca 10
EU - Europa 8
RU - Federazione Russa 8
JP - Giappone 5
BR - Brasile 4
CH - Svizzera 4
NL - Olanda 4
ID - Indonesia 3
AR - Argentina 2
CL - Cile 2
ET - Etiopia 2
HU - Ungheria 2
IR - Iran 2
MX - Messico 2
PA - Panama 2
PL - Polonia 2
PT - Portogallo 2
SA - Arabia Saudita 2
CO - Colombia 1
DK - Danimarca 1
EC - Ecuador 1
ES - Italia 1
HK - Hong Kong 1
LT - Lituania 1
MD - Moldavia 1
MY - Malesia 1
PE - Perù 1
PH - Filippine 1
RS - Serbia 1
TW - Taiwan 1
Totale 7.003
Salva come PNG Salva come JPEG
Città #
Dublin 932
Chandler 536
Jacksonville 428
Dearborn 325
Nyköping 291
Nanjing 205
Beijing 117
Singapore 106
Wilmington 102
Princeton 98
Ashburn 84
Nanchang 71
Ann Arbor 70
New York 66
San Mateo 63
Des Moines 49
Boardman 47
Shenyang 47
Hebei 44
Helsinki 41
Rome 41
Tianjin 39
Hilden 36
Woodbridge 33
Jiaxing 32
Foggia 30
Kunming 30
Pune 29
Hangzhou 28
Jinan 27
Vienna 25
Munich 23
Los Angeles 22
Changsha 18
Guangzhou 17
Ningbo 17
Milan 14
Brussels 13
Wuhan 13
Dong Ket 12
Falls Church 12
San Severo 12
Zhengzhou 12
Bari 11
Lanzhou 10
Norwalk 10
Shanghai 10
Auburn Hills 9
Washington 9
Houston 8
Redwood City 8
Hefei 7
Santeramo In Colle 7
Kocaeli 6
Naples 6
Orange 6
Seattle 6
Taizhou 6
Venice 6
Brno 5
Changchun 5
New Delhi 5
Perugia 5
Saarbrücken 5
Baltimore 4
Bologna 4
Caserta 4
Fuzhou 4
Paris 4
Philadelphia 4
Reno 4
Rockville 4
Tappahannock 4
Cassino 3
Catania 3
Düsseldorf 3
Genova 3
Manfredonia 3
Newark 3
Niedernberg 3
Pavia 3
Pimonte 3
Saga 3
Stockholm 3
Toronto 3
Turin 3
Waterloo 3
Xinxiang 3
Zurich 3
Addis Ababa 2
Ahmedabad 2
Ancona 2
Augusta 2
Borås 2
Buenos Aires 2
Buffalo 2
Cagliari 2
Cattolica 2
Chicago 2
Chongqing 2
Totale 4.513
Salva come PNG Salva come JPEG
Nome #
Use of mammalian target of rapamycin inhibitor for treating pathologies including neurodegenerative diseases (Alzheimer's disease), neuroinflammatory diseases and tumor diseases with neurological involvement, by intrathecal administration 168
Effects of perinatal exposure to delta-9-tetrahydrocannabinol on the emotional reactivity of the offspring: a longitudinal behavioral study in wistar rats. 131
Social memory impairment in a triple-transgenic mouse model of Alzhemer's disease is accompained by monoaminergic alterations 120
The cannabinoid agonist WIN55212-2 normalizes levodopa-induced volume transmission unbalances across the two brain hemispheres of dyskinetic rats 112
Data available on the extent of cocaine use and dependence: Biochemistry, pharmacologic effects and global burden of disease of cocaine abusers. 109
Cannabinoid receptor agonist WIN 55,212-2 inhibits rat cortical dialysate gamma-aminobutyric acid levels 106
Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis 106
Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: Role of CB(1) and TRPV1 receptors 105
Mice lacking fatty acid amide hydrolase (FAAH-/-) showed increased serotonergic neurotransmission and reduced emotional reactivity 104
Biochemical and Neurobehavioral Profile of CHF2819, a Novel, Orally Active Acetylcholinesterase Inhibitor for Alzheimer’s Disease 104
Chronic psychosocial defeat differently affects lipid metabolism in liver and white adipose tissue and induces hepatic oxidative stress in mice fed a high-fat diet 101
Glutamate and mitochondria: two prominent players in the oxidative stress-induced neurodegeneration 100
Antinutritional effects of fumonisin B1 and pathophysiological consequences 96
Alterations of Clock Gene RNA Expression in Brain Regions of a Triple Transgenic Model of Alzheimer’s Disease 95
Prenatal exposure to the cannabinoid receptor agonist WIN 55,212-2 increases glutamate uptake through overexpression of GLT1 and EAAC1 glutamate transporter subtypes in rat frontal cerebral cortex 94
Cannabinoids normalize neurochemical unbalances across the two hemispheres of dyskinetic rats 94
Perinatal exposure to delta-9-tetrahydrocannabinol causes enduring cognitive deficits associated with alteration of cortical gene expression and neurotransmission in rats 93
Monoaminergic changes in locus coeruleus and dorsal raphe nucleus following noradrenaline depletion 92
Preclinical progress with CHF2819, a novel orally active acetylcholinesterase inhibitor 90
Principles and therapeutic relevance for targeting mitochondria in aging and neurodegenerative diseases. 90
Aberrant insulin signaling in Alzheimer's disease: current knowledge 88
Effects of early postnatal exposure to low concentrations of carbon monoxide on cognitive functions in rats 87
5-S-cysteinyldopamine neurotoxicity: Influence on the expression of α-synuclein and ERp57 in cellular and animal models of Parkinson's disease 86
Prenatal exposure to low concentrations of carbon monoxide alters habituation and non-spatial working memory in rat offspring 85
Cannabinoid receptor 2 signaling in neurodegenerative disorders: From pathogenesis to a promising therapeutic target 85
Striatal 6-Ohda Lesion In Mice: Investigating Early Neurochemical Changes Underlying Parkinson's Disease 84
The satiety signal oleoylethanolamide stimulates oxytocin neurosecretion from rat hypothalamic neurons 84
Ultramicronized palmitoylethanolamide rescues learning and memory impairments in a triple transgenic mouse model of Alzheimer's disease by exerting anti-inflammatory and neuroprotective effects 84
Activation of PPAR gamma receptors reduces levodopa-induced dyskinesias in 6-OHDA-lesioned rats 83
Intranasal delivery of dopamine to the striatum using glycol chitosan/sulfobutylether-β-cyclodextrin based nanoparticles 83
Effects of prenatal exposure to low concentrations of carbon monoxide on sexual behaviour and mesolimbic dopaminergic function in rat offspring 82
Loss of biliverdin reductase-A favors Tau hyper-phosphorylation in Alzheimer's disease 82
Depressive-like behavior is paired to monoaminergic alteration in a murine model of Alzheimer's disease 81
Neurokinin 1 receptor antagonism requires norepinephrine to increase serotonin function 80
CHF2819: pharmacological profile of a novel acetylcholinesterase inhibitor 80
The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs 79
MITOCHONDRIAL DYSFUNCTIONS IN A TRANSGENIC MURINE MODEL OF ALZHEIMER’S DISEASE 78
Biological mechanisms associated with increased perseveration and hyperactivity in a genetic mouse model of neurodevelopmental disorder 78
Evaluation of the emotional phenotype and serotonergic neurotransmission of fatty acid amide hydrolase-deficient mice 78
Role of the area postrema in the hypophagic effects of oleoylethanolamide 77
Glutamatergic alterations and mitochondrial impairment in a murine model of Alzheimer disease 77
Novel codrugs with GABAergic activity for dopamine delivery in the brain 76
Brain Histamine Is Crucial for Selective Serotonin Reuptake Inhibitors' Behavioral and Neurochemical Effects 76
Biliverdin Reductase-A Mediates the Beneficial Effects of Intranasal Insulin in Alzheimer Disease 75
Altered serotonergic function may partially account for behavioral endophenotypes in steroid sulfatase-deficient mice 75
Prenatal Exposure to the CB1 Receptor Agonist Win 55,212-2 Causes Learning Disruption Associated With Impaired Cortical NMDA Receptor Function and Emotional Reactivity Changes in Rat Offspring 74
Altered expression of the CB1 cannabinoid receptor in the triple transgenic mouse model of Alzheimer's disease. 74
Altered regulation of glutamate release and decreased functional activity and expression of GLT1 and GLAST glutamate transporters in the hippocampus of adolescent rats perinatally exposed to Delta(9)-THC. 73
Characterization and evaluation of chitosan nanoparticles for dopamine brain delivery 72
Inhibition of anandamide hydrolysis enhances noradrenergic and GABAergic transmission in the prefrontal cortex and basolateral amygdala of rats subjected to acute swim stress 72
Impairment of biliverdin reductase-A promotes brain insulin resistance in Alzheimer disease: A new paradigm 72
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis 72
Neurochemical and neurobehavioral effects of ganstigmine (CHF2819), a novel acetylcholinesterase inhibitor, in rat prefrontal cortex: An in vivo study 71
The effects of oleoylethanolamide on feeding behaviour involve hypothalamic oxytocin neurons 69
Olfactory memory is impaired in a triple transgenic model of Alzheimer disease 69
Neurochemical changes in the striatum of dyskinetic rats after administration of the cannabinoid agonist WIN55,212-2 68
Prenatal exposure to the cannabinoid receptor agonist WIN 55,212-2 and carbon monoxide reduces extracellular glutamate levels in primary rat cerebral cortex cell cultures 67
Evaluation of a LC-MS method for everolimus preclinical determination in brain by using [(13)C2D4]RAD001 internal standard 66
Palmitoylethanolamide Dampens Reactive Astrogliosis and Improves Neuronal Trophic Support in a Triple Transgenic Model of Alzheimer’s Disease: In Vitro and In Vivo Evidence 66
Linking lipid peroxidation and neuropsychiatric disorders: focus on 4-hydroxy-2-nonenal 65
The fat-induced satiety factor oleoylethanolamide suppresses feeding through central release of oxytocin 64
Early intrathecal infusion of everolimus restores cognitive function and mood in a murine model of Alzheimer's disease 64
Genetic factors involved in the effects of developmental low-level alcohol induced behavioral alterations in rats 63
Role of the basolateral amygdala in mediating the effects of the fatty acid amide hydrolase inhibitor URB597 on HPA axis response to stress 63
Hindbrain noradrenergic input to the hypothalamic PVN mediates the activation of oxytocinergic neurons induced by the satiety factor oleoylethanolamide 62
Evidence for an imbalance between tau O-GlcNAcylation and phosphorylation in the hippocampus of a mouse model of Alzheimer's disease 61
Effects of ENA713 and CHF2819, two anti-Alzheimer’s disease drugs, on rat amino acid levels 60
Nonmotor symptoms in Parkinson's disease: Investigating early-phase onset of behavioral dysfunction in the 6-hydroxydopamine-lesioned rat model 59
The effects of nitric oxide on striatal serotoninergic transmission involve multiple targets: An in vivo microdialysis study in the awake rat 59
Neurochemical changes produced by CHF2819, a novel, orally active acetylcholinesterase inhibitor, in rat brain 58
The role of endocannabinoid signaling in the molecular mechanisms of neurodegeneration in Alzheimer's disease 58
Modulation of the oxidative stress and lipid peroxidation by endocannabinoids and their lipid analogues 58
Astrocyte function is affected by aging and not Alzheimer's disease: A preliminary investigation in hippocampi of 3xTg-AD mice 58
Insulin signaling: An opportunistic target to minify risk of Alzheimer's disease 57
Interaction between Cognitive Reserve and Biomarkers in Alzheimer Disease 57
From Cannabis sativa to Cannabidiol: Promising Therapeutic Candidate for the Treatment of Neurodegenerative Diseases 56
Short- and long-term consequences of prenatal exposure to the cannabinoid agonist WIN55,212-2 on rat glutamate transmission and cognitive functions. 55
From obesity resistance to obesity prediction and prevention? 55
Delta9-Tetrahydrocannabinol increases endogenous extracellular glutamate levels in primary cultures of rat cerebral cortex neurons. Involvement of CB1 receptors 53
Oleoylethanolamide decreases frustration stress-induced binge-like eating in female rats: a novel potential treatment for binge-eating disorder 53
Proteomic identification of altered protein O-GlcNAcylation in a triple transgenic mouse model of Alzheimer's disease 51
Editorial: Dysmetabolism, obesity, and inflammation: Three prominent actors in the drama of major neuropsychiatric disorders 51
Pharmacological treatment of depression in Alzheimer's disease: A challenging task 50
Genetic deletion of fatty acid amide hydrolase alters emotional behavior and serotonergic transmission in the dorsal raphe, prefrontal cortex, and hippocampus 50
Inhibition of fatty-acid amide hydrolase and CB1 receptor antagonism differentially affect behavioural responses in normal and PCP-treated rats 49
Oxidative Stress in Aging Brain: Nutritional and Pharmacological Interventions for Neurodegenerative Disorders 48
Liver fat content assessed by conventional B-mode ultrasound and metabolic profile in non-diabetic patients: Implications for clinical practice 47
TFEB activation restores migration ability to Tsc1-deficient adult neural stem/progenitor cells 46
Compromised decision-making and increased gambling proneness following dietary serotonin depletion in rats 46
Histamine-deficient mice do not respond to the antidepressant-like effects of oleoylethanolamide 46
Differential Effects of Palmitoylethanolamide against Amyloid-β Induced Toxicity in Cortical Neuronal and Astrocytic Primary Cultures from Wild-Type and 3xTg-AD Mice 45
Oxazepam-Dopamine Conjugates Increase Dopamine Delivery into Striatum of Intact Rats 45
Psychosomatic syndromes are associated with IL-6 pro-inflammatory cytokine in heart failure patients 39
Depressive-like behavior is paired to monoaminergic alteration in a murine model of Alzheimer's disease 37
Genetic Polymorphisms and Clinical Features in Diabetic Patients With Fatty Liver: Results From a Single-Center Experience in Southern Italy 36
Lung histopathological findings in COVID-19 disease - a systematic review 35
The glucose metabolic pathway as a potential target for therapeutics: Crucial role of glycosylation in alzheimer’s disease 32
Prevalence and risk factors for hospital-acquired anemia in internal medicine patients: learning from the "less is more" perspective 30
The dual role of glutamatergic neurotransmission in Alzheimer’s disease: From pathophysiology to pharmacotherapy 30
Autoimmune liver disease and multiple sclerosis: state of the art and future perspectives 29
Totale 7.198
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.353
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.353
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020890 0 0 0 0 183 184 227 29 100 20 125 22
2020/2021860 114 8 102 68 110 70 112 13 115 131 1 16
2021/2022538 64 11 4 8 39 14 12 38 89 76 30 153
2022/20232.350 202 96 96 158 115 230 39 194 1.104 23 46 47
2023/2024472 61 32 17 23 46 157 21 11 2 11 2 89
2024/2025315 85 19 79 64 68 0 0 0 0 0 0 0
Totale 7.393